Russian and British coronavirus vaccines may combine
RUSSIA / FSU POLITICS
- In Brief
12 Dec 2020
by Alex Teddy
On December 11 it was announced that the maker of Sputnik V will join forces with AstraZeneca to try to make a join coronavirus vaccine. The British coronavirus vaccine is made at Oxford. The Gamaleya Research Center developed Sputnik V. The state run laboratory's vaccine has met with widespread scepticism among Russian doctors.Both vaccines are adenovirus based. The two formidable intend to test a new combine vaccine on adults when it is developed. AstraZeneca invented AZD1222. On December 8 they published their final clinical trial data in a scholarly journal. No other vaccine makers have done this. AZD1222 works in only 70% of cases. It costs less and is more mobile than its alternatives. It does not need to be kept in super cold temperatures unlike most coronavirus vaccines.Sputnik V is supposed to be provided to over two million people by the end of 2020.Gamaleya has not published interim date on Sputnik V. This has perturbed many physicians. Gamaleya said it will publish the data in December 2020. Sputnik V is said to be 96% effectual after two shots.
Now read on...
Register to sample a report